144 related articles for article (PubMed ID: 8840148)
1. A quantity of stereotyped behavior of ddY mice induced by low-dose methamphetamine.
Masuda Y; Matsuda Y; Kondoh M; Shimizu T; Hishikawa Y
Exp Anim; 1996 Jul; 45(3):279-81. PubMed ID: 8840148
[TBL] [Abstract][Full Text] [Related]
2. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats.
Li X; Jiang F; Yao K; Yang L; Gao X; Chen H; Wei X; Wu N; Zhou R; Yuan W; Zhang S
Biochem Biophys Res Commun; 2020 Jun; 527(1):98-103. PubMed ID: 32446398
[TBL] [Abstract][Full Text] [Related]
4. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
[TBL] [Abstract][Full Text] [Related]
5. Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tatsuta T; Morita Y; Tanaka K; Nishiyama N; Takemura M
Neurochem Res; 2011 Oct; 36(10):1824-33. PubMed ID: 21573995
[TBL] [Abstract][Full Text] [Related]
6. Psychomotor effect differences between l-methamphetamine and d-methamphetamine are independent of murine plasma and brain pharmacokinetics profiles.
Nishimura T; Takahata K; Kosugi Y; Tanabe T; Muraoka S
J Neural Transm (Vienna); 2017 May; 124(5):519-523. PubMed ID: 28213761
[TBL] [Abstract][Full Text] [Related]
7. Altered locomotor and stereotyped responses to acute methamphetamine in adolescent, maternally separated rats.
Pritchard LM; Hensleigh E; Lynch S
Psychopharmacology (Berl); 2012 Sep; 223(1):27-35. PubMed ID: 22414962
[TBL] [Abstract][Full Text] [Related]
8. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
9. Mazindol: anorectic and behavioral effects in female rats.
Mattei R; Carlini EA
Arch Int Pharmacodyn Ther; 1995; 330(3):279-87. PubMed ID: 8836447
[TBL] [Abstract][Full Text] [Related]
10. Individual differences are critical in determining modafinil-induced behavioral sensitization and cross-sensitization with methamphetamine in mice.
Soeiro Ada C; Moreira KD; Abrahao KP; Quadros IM; Oliveira MG
Behav Brain Res; 2012 Aug; 233(2):367-74. PubMed ID: 22652394
[TBL] [Abstract][Full Text] [Related]
11. Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains.
Grisel JE; Belknap JK; O'Toole LA; Helms ML; Wenger CD; Crabbe JC
J Neurosci; 1997 Jan; 17(2):745-54. PubMed ID: 8987796
[TBL] [Abstract][Full Text] [Related]
12. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
[TBL] [Abstract][Full Text] [Related]
13. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
15. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
Chen PC; Lao CL; Chen JC
J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
[TBL] [Abstract][Full Text] [Related]
16. Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
Ago Y; Takahashi K; Nakamura S; Hashimoto H; Baba A; Matsuda T
J Pharmacol Sci; 2007 Jun; 104(2):153-8. PubMed ID: 17538228
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy.
Hashimoto A; Konno R; Yano H; Yoshikawa M; Tamaki R; Matsumoto H; Kobayashi H
Eur J Pharmacol; 2008 May; 586(1-3):221-5. PubMed ID: 18448092
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of N-cyanomethylmethamphetamine, a product derived from smoking methamphetamine with tobacco, in mice and rats.
Sekine H; Nagao S; Kuribara H; Nakahara Y
Pharmacol Biochem Behav; 1997; 57(1-2):167-72. PubMed ID: 9164568
[TBL] [Abstract][Full Text] [Related]
19. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
[TBL] [Abstract][Full Text] [Related]
20. Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption.
Scibelli AC; McKinnon CS; Reed C; Burkhart-Kasch S; Li N; Baba H; Wheeler JM; Phillips TJ
Psychopharmacology (Berl); 2011 Apr; 214(4):791-804. PubMed ID: 21088960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]